LSE:MXCN

MaxCyte Acquires SeQure Dx to Broaden Cell Engineering Offerings with On-target and Off-target Editing Assessments

January 30, 2025 02:00 ET  | Source: MaxCyte, Inc ROCKVILLE, Md., Jan. 30, 2025 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq:…

2 months ago

MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial Results

January 13, 2025 03:05 ET  | Source: MaxCyte, Inc ROCKVILLE, Md., Jan. 13, 2025 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq:…

3 months ago

MaxCyte Announces Retirement of Board Member Art Mandell

December 23, 2024 02:00 ET  | Source: MaxCyte, Inc ROCKVILLE, Md., Dec. 22, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq:…

4 months ago